Search Results
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Centre for Clinical Research in Sörmland, Uppsala University, Uppsala, Sweden
Search for other papers by Emil Mikulski in
Google Scholar
PubMed
Search for other papers by Erik H. Larsen in
Google Scholar
PubMed
Centre for Clinical Research in Sörmland, Uppsala University, Uppsala, Sweden
Search for other papers by Marika Möller in
Google Scholar
PubMed
hormones and low thyroid-stimulating hormone (TSH). Patients typically develop physical and mental symptoms such as tachycardia, weight loss, sweating, muscle weakness, tremor and anxiety [ 2 ]. Medication blocking the thyroid hormone synthesis is one
Search for other papers by John Lazarus in
Google Scholar
PubMed
Search for other papers by Rosalind S. Brown in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) in pregnancy is defined by a serum thyroid-stimulating hormone (TSH) concentration higher than the upper limit of the pregnancy-related reference range associated with a normal serum thyroxine [T 4
Search for other papers by Bharath Bachimanchi in
Google Scholar
PubMed
Search for other papers by Suresh Vaikkakara in
Google Scholar
PubMed
Search for other papers by Alok Sachan in
Google Scholar
PubMed
Search for other papers by Ganji Praveen Kumar in
Google Scholar
PubMed
Search for other papers by Ashok Venkatanarasu in
Google Scholar
PubMed
Search for other papers by Palaparti Sai Krishna Chaitanya in
Google Scholar
PubMed
Search for other papers by Bekkem Sreedivya in
Google Scholar
PubMed
Search for other papers by Ravi Poojari in
Google Scholar
PubMed
(FSH), luteinizing hormone (LH), and prolactin (PRL) ≥2 months after the normalization of thyroid-stimulating hormone (TSH) in hypothyroid women. Materials and Methods This study was a prospective, longitudinal, before/after, interventional
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Hongcheng Wei in
Google Scholar
PubMed
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Quanquan Guan in
Google Scholar
PubMed
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Qiurun Yu in
Google Scholar
PubMed
Search for other papers by Ting Chen in
Google Scholar
PubMed
Search for other papers by Xu Wang in
Google Scholar
PubMed
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
Search for other papers by Yankai Xia in
Google Scholar
PubMed
( 10 , 11 ). It is commonly acknowledged that free thyroxine (FT4), thyroid-stimulating hormone (TSH) and thyroid peroxidase antibody (TPOAb) serve as the primary indicators of thyroid function. Moreover, maternal thyroid dysfunction has been
Search for other papers by Alies A. van Mullem in
Google Scholar
PubMed
Search for other papers by Theo J. Visser in
Google Scholar
PubMed
Search for other papers by Robin P. Peeters in
Google Scholar
PubMed
the ligand-binding domain of THRB are associated with resistance to TH (RTHβ). RTHβ is characterized by high serum TH levels in combination with nonsuppressed thyroid-stimulating hormone (TSH). The syndrome may comprise goiter, tachycardia, and
Search for other papers by Paolo Cavarzere in
Google Scholar
PubMed
Search for other papers by Laura Palma in
Google Scholar
PubMed
Search for other papers by Lara Nicolussi Principe in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Monica Vincenzi in
Google Scholar
PubMed
Search for other papers by Silvana Lauriola in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Rossella Gaudino in
Google Scholar
PubMed
Search for other papers by Virginia Murri in
Google Scholar
PubMed
Search for other papers by Luigi Lubrano in
Google Scholar
PubMed
Search for other papers by Giuliana Rossi in
Google Scholar
PubMed
Search for other papers by Alessia Sallemi in
Google Scholar
PubMed
Search for other papers by Ermanna Fattori in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Marta Camilot in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Regional Center for the Diagnosis and Treatment of Children and Adolescents Rare Skeletal Disorders, Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Franco Antoniazzi in
Google Scholar
PubMed
.1177/0009922817729484 ) 11 Evans C Gregory JW Barton J Bidder C Gibbs J Pryce R Al-Muzaffar I Ludgate M Warner J John R Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case series . Annals of
Search for other papers by Earn H. Gan in
Google Scholar
PubMed
Search for other papers by Anna L. Mitchell in
Google Scholar
PubMed
Search for other papers by Ruth Plummer in
Google Scholar
PubMed
Search for other papers by Simon Pearce in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
clinical evidence of Graves orbitopathy. Biochemical tests showed a serum thyroid-stimulating hormone (TSH) which was fully suppressed with a raised free T3 of 13.0 pmol/L (reference range 3.5–6.5) and free T4 of 27.6 pmol/L (reference range 9
Search for other papers by João Anselmo in
Google Scholar
PubMed
Search for other papers by Carolina M. Chaves in
Google Scholar
PubMed
positively regulated genes, certain genes are negatively regulated by T 3 . This is the case with the thyrotropin/thyroid-stimulating hormone (TSH) gene, critical for the feedback control of the TH axis. The TSH gene is downregulated by T 3 and
Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed
Search for other papers by Line Tang Møllehave in
Google Scholar
PubMed
Search for other papers by Bjarke Røssner Medici in
Google Scholar
PubMed
Search for other papers by Christian Zinck Jensen in
Google Scholar
PubMed
Search for other papers by Anne Ahrendt Bjerregaard in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
the quality of life has been debated for many years ( 1 ), while the use of thyroid hormone has increased worldwide. In Denmark, from 2001 to 2015, an increase of 132% was seen, simultaneously, with a decrease in the thyroid-stimulating hormone (TSH
Search for other papers by Joke Marlier in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Jean Kaufman in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
relatively straightforward, optimal TH replacement in patients with CHT is more challenging. This is because of the impossibility to be guided by thyroid-stimulating hormone (TSH) serum level as TSH levels may be low, normal or mildly elevated at diagnosis